Clinical Trials Logo
  1. Home
  2. Sjögren Syndrome
  3. NCT05349214

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome — NEPTUNUS-2  

Sjogren Syndrome Clinical Trial

Official title:
A Randomized, Double-blind, Placebo Controlled, 3-arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

Clinical Trial Summary

A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjogren's syndrome (NEPTUNUS-2)

Clinical Trial Description

Three-arm study of the clinical efficacy, safety and tolerability of ianalumab (VAY736) in patients with active Sjogren's syndrome. The purpose of this study is to demonstrate the clinical efficacy, safety and tolerability of ianalumab (VAY736) administered subcutaneously (s.c.) monthly or every 3 months compared to placebo in patients with active Sjogren's syndrome. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05349214
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone 1-888-669-6682
Email novartis.email@novartis.com
Status Recruiting
Phase Phase 3
Start date August 4, 2022
Completion date March 9, 2028
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03839069 - Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis N/A
Completed NCT03865888 - Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome Phase 3
Terminated NCT04988087 - A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) Phase 2
Completed NCT02257957 - Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye Phase 3
Completed NCT01647737 - Green Tea Lozenges for the Management of Dry Mouth Phase 1/Phase 2
Recruiting NCT02450396 - Pregnancy and Medically Assisted Conception in Rare Diseases
Active, not recruiting NCT05350072 - Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Phase 3
Active, not recruiting NCT05124925 - Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments. Phase 2
Recruiting NCT03816345 - Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Phase 1
Active, not recruiting NCT02132585 - Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction N/A
Completed NCT01850979 - Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops Phase 4